Skip to main content
. 2023 Oct 26;11(11):1642. doi: 10.3390/vaccines11111642
α1-adr-R-AB Alpha-1 adrenergic receptor antibody
α2a-adr-R-AB Alpha-2A adrenergic receptor antibody
α2b-adr-R-AB Alpha-2B adrenergic receptor antibody
α2c-adr-R-AB Alpha-2C adrenergic receptor antibody
ACE-II-AB Angiotensin-converting enzyme 2 antibody
AT1R-AB Angiotensin II type 1 receptor antibody
β1-adr-R-AB Beta-1 adrenergic receptor antibody
β2-adr-R-AB Beta-2 adrenergic receptor antibody
CRP C-reactive protein
ETAR-AB Endothelin-1 type A receptor antibody
IL-1-Rb-AB Interleukin-1 receptor type 2 antibody
IL-6/-8 Interleukin 6/8
M1R-AB muscarinic acetylcholine receptor M1
M2R-AB muscarinic acetylcholine receptor M2
M3R-AB muscarinic acetylcholine receptor M3
M4R-AB muscarinic acetylcholine receptor M4
M5R-AB muscarinic acetylcholine receptor M5
MASR-AB MAS 1 receptor antibody
MCAS Mast cell activation syndrome
ME/CFS Myalgic encephalomyelitis/chronic fatigue syndrome
NAB PanIg reactivity against SARS-CoV-1 nucleocapsid protein
pBNP pro-brain natriuretic peptide
PEM Post exertional malaise
POTS Postural tachycardia syndrome
PACVS Post-acute COVID-19 vaccination syndrome
ROC Receiver-operator characteristics
SAB PanIg reactivity against SARS-CoV-1 spike S1 protein
SFN Small fiber neuropathy